InvestorsHub Logo
Followers 840
Posts 120458
Boards Moderated 18
Alias Born 09/05/2002

Re: urche post# 5217

Friday, 11/01/2019 12:15:12 PM

Friday, November 01, 2019 12:15:12 PM

Post# of 6747

I am curious what theories we have about why the sudden spike in volume, seemingly on no news since the disappointing trial results about a month ago.

The impetus was Roche’s deal with DRNA announced yesterday to develop RNAi drugs for HBV (#msg-152014949).

I'm not especially bullish on ABUS, but I'm following it because I'm long ENTA, who has an HBV program that will soon start phase-1. Regards, Dew

p.s. Welcome back to iHub!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News